Back to User profile » Dr Fangfang Xu
Papers published by Dr Fangfang Xu:
Association Between Plasma Levels of ANGPTL3, 4, 8 and the Most Common Additional Cardiovascular Risk Factors in Patients with Hypertension
Xu F, Shen L, Yang Y, Kong L, Zu W, Tian D, Cao X, Huang G
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1647-1655
Published Date: 7 June 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
ANGPTL8/Betatrophin Improves Glucose Tolerance in Older Mice and Metabolomic Analysis Reveals Its Role in Insulin Resistance in HepG2 Cells
Xu F, Wang N, Li G, Tian D, Shi X
Diabetes, Metabolic Syndrome and Obesity 2021, 14:4209-4221
Published Date: 11 October 2021
Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia
Pei Y, Shi M, Song J, Niu X, Wei S, Dou L, Xiao M, Li D, Xu F, Bai Y, Sun K
Cancer Management and Research 2021, 13:4135-4146
Published Date: 21 May 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Prognostic Significance Of The Inflammatory Index-Based Scoring System In Patients Preliminarily Diagnosed With Multiple Myeloma In The Bortezomib-Based Chemotherapy Era
Liu S, Shi J, Guo H, Xu F, Wei M, Sun K, Chen Y
Cancer Management and Research 2019, 11:9409-9420
Published Date: 5 November 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
Shi M, Xu F, Yang X, Bai Y, Niu J, Drokow EK, Chen M, Chen Y, Sun K
Cancer Management and Research 2019, 11:8229-8238
Published Date: 6 September 2019